Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Novartis
Healthtrust
Baxter
Fish and Richardson
McKesson
Dow
Merck
McKinsey
Moodys

Generated: August 23, 2017

DrugPatentWatch Database Preview

DICLOXACILLIN SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Dicloxacillin Sodium, and what generic Dicloxacillin Sodium alternatives are available?

Dicloxacillin Sodium is a drug marketed by Sandoz, Apothecon, and Teva. and is included in three NDAs.

The generic ingredient in DICLOXACILLIN SODIUM is dicloxacillin sodium. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.

Summary for Tradename: DICLOXACILLIN SODIUM

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list15
Bulk Api Vendors: see list61
Clinical Trials: see list2,375
Patent Applications: see list3,724
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DICLOXACILLIN SODIUM at DailyMed

Pharmacology for Tradename: DICLOXACILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
DICLOXACILLIN SODIUM
dicloxacillin sodium
CAPSULE;ORAL061454-002Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
DICLOXACILLIN SODIUM
dicloxacillin sodium
FOR SUSPENSION;ORAL061455-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
DICLOXACILLIN SODIUM
dicloxacillin sodium
CAPSULE;ORAL061454-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
DICLOXACILLIN SODIUM
dicloxacillin sodium
CAPSULE;ORAL061454-003Approved Prior to Jan 1, 1982ABRXNoYes► Subscribe► Subscribe► Subscribe
Teva
DICLOXACILLIN SODIUM
dicloxacillin sodium
CAPSULE;ORAL062286-002Jun 3, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Julphar
Merck
Harvard Business School
Johnson and Johnson
Moodys
AstraZeneca
Novartis
Covington
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot